PacBio reveals financial results for Q4 and FY 2024

Sequencing technology has revolutionized the field of genomics, offering researchers the ability to decode DNA with unprecedented accuracy and speed. Among the cutting-edge sequencing systems available today are the Revio long-read system, the Vega long-read system, and the Onso short-read system. These systems leverage advanced technologies like HiFi long-read sequencing, SBB short-read sequencing, Kinnex, PureTarget, and Nanobind DNA extraction.

In addition to these sequencing systems, there are various consumables designed to streamline the sequencing process. These consumables include sample prep kits, application kits, library prep and barcoding materials, as well as HiFi and Onso sequencing products. Researchers can choose from a range of sequencing methods such as whole genome sequencing, targeted sequencing, RNA sequencing, epigenetics research, and microbiome/metagenomics studies.

To support researchers in their sequencing endeavors, PacBio provides a wide range of software and bioinformatics tools. The SMRT Link software suite offers computational tools for data analysis, while the Onso software provides seamless integration with compatible partner software. Researchers can also access support for purchasing equipment, financing options through PacBio Capital, global distributor information, compatible products, and certified service providers.

The focus areas of PacBio’s sequencing technology span across various fields of genomics. In human genomics, PacBio technology is utilized for genetic testing, clinical research, rare disease studies, repeat expansions, population genomics, and more. The HiFi Solves initiative aims to address challenges in human research, neurogenomics, immunogenomics, and other related areas.

Microbial genomics is another key focus area, with applications in public health surveillance, infectious disease research, and the study of plant and animal microbes. Plant and animal genomics research addresses topics like agrigenomics, biodiversity, and plant/animal biology. Cancer genomics research, on the other hand, focuses on liquid biopsy techniques, biopharma applications, gene therapy, gene editing, and biologics R&D.

For researchers looking to engage with PacBio’s technology, there are various resources available. These include opportunities to become a sequencing service provider, access datasets, apply for grants, and connect with certified service providers and distributors. PacBio’s educational resources include blogs, webinars, case studies, scientific publications, posters, literature, and educational videos.

Furthermore, PacBio offers robust support to its customers, with technical support scientists, engineers, and bioinformaticians available to assist with any queries or issues. Support is available Monday to Friday from 7 AM to 5 PM PST via email or phone. Additionally, a comprehensive documentation library includes technical support, FAQs, training materials, software downloads, protocols, certifications, and safety data sheets.

In conclusion, PacBio’s sequencing technology and services cater to diverse research needs across human genomics, microbial genomics, plant and animal genomics, cancer genomics, and more. With a wide range of systems, consumables, software, and support options, PacBio aims to empower researchers in their quest to unravel the mysteries of the genome.